Hypermethylation of the microRNA miR-124, miR-125b, miR-127, and miR-129 in Ovarian Carcinoma Is Involved in Suppression of Their Expression and Associated With Both the Development and Progression of Ovarian Cancer

Almanac of Clinical Medicine
doi 10.18786/2072-0505-2019-47-003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Moscow Regional Research and Clinical Institute (MONIKI)

Related search

Clinical Relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Decreased Expression of miR-125b and miR-100 in Oral Cancer Cells Contributes to Malignancy

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2009English

Dysregulation of miR-106a and miR-591 Confers Paclitaxel Resistance to Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2013English

The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis

International Journal of Oncology
Cancer ResearchOncology
2014English

miR-28-5p Promotes the Development and Progression of Ovarian Cancer Through Inhibition of N4BP1

International Journal of Oncology
Cancer ResearchOncology
2017English

Expression of miR-224-5p Is Associated With the Original Cisplatin Resistance of Ovarian Papillary Serous Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2014English

IFN-α Regulates Blimp-1 Expression via miR-23a and miR-125b in Both Monocytes-Derived DC and pDC

PLoS ONE
Multidisciplinary
2013English

Overexpression of miR‑221 and miR‑222 in the Cancer Stroma Is Associated With Malignant Potential in Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

The miR-200 Family Controls -Tubulin III Expression and Is Associated With Paclitaxel-Based Treatment Response and Progression-Free Survival in Ovarian Cancer Patients

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy